×÷ΪÖйúµÚÈý·½¼ì²âÓëÈÏÖ¤·þÎñµÄ¿ªÍØÕߺÍÁìÏÈÕߣ¬CTI9888À˹ά¼Ó˹¼ì²âΪȫÇò¿Í»§ÌṩһվʽĥÁ·¡¢²âÊÔ¡¢Ð£×¼¡¢ÈÏÖ¤¼°ÊÖÒÕ·þÎñ¡£
·þÎñÄÜÁ¦ÒÑÖÜÈ«ÁýÕÖµ½·ÄÖ¯´ò°ç¼°Ð¬°ü¡¢Ó¤Í¯Íæ¾ß¼°¼Ò¾ÓÉúÑÄ¡¢µç×ÓµçÆ÷¡¢Ò½Ñ§¿µ½¡¡¢Ê³Îï¼°Å©²úÆ·……µÈÐÐÒµµÄ¹©Ó¦Á´ÉÏÏÂÓΡ£
ÖÜÈ«°ü¹ÜÆ·ÖÊÓëÇå¾²£¬Íƶ¯ºÏ¹æÓëÁ¢Ò죬ÕÃÏÔÆ·ÅƾºÕùÁ¦£¬ÊµÏÖ¸ü¸ßÖÊÁ¿¡¢¸ü¿µ½¡¡¢¸üÇå¾²¡¢¸üÂÌÉ«µÄ¿ÉÒ»Á¬Éú³¤¡£
Ê×Ò³ > ÎÒÃǵķþÎñ > Ò½Ò©¼°Ò½Ñ§·þÎñ > Ò½ÁÆÆ÷е¼ì²â > ·þÎñÏêÇé
CTI9888À˹ά¼Ó˹¼ì²âΪÄúÌṩ³¬Éù½àÑÀ×°±¸×¢²á¼ì²â½â¾ö¼Æ»®£¬¿ÉÁýÕֵļì²â·þÎñ¹æÄ£ÓУºÒ½ÁÆÆ÷еµçÆøÇå¾²¡¢EMC²âÊÔ¡¢ÉúÎïÏàÈÝÐÔ²âÊÔ¡¢°ü×°ÔËÊä¼°ÀÏ»¯ÊµÑ顢ϴåªÏû¶¾Ãð¾úÑéÖ¤µÈ·þÎñ¡£
Σº¦Æ·¼¶·ÖÀà
ÔÚÎÒ¹úµÄÒ½ÁÆÆ÷еע²á¹ÜÀíÖУ¬³¬Éù½àÑÀ×°±¸Î£º¦¹ÜÀíÖÖ±ðÓÐIIÀà;
ÖµµÃ×¢ÖØµÄÊÇ£¬×÷Ϊ³¬Éù½àÑÀ»úµÄÅäÌ׸½¼þ£¬³¬Éù½àÑÀ»úÊÂÇé¼âÔòÊôÓÚ¢ñÀàÒ½ÁÆÆ÷е¡£
³¬Éù½àÑÀ×°±¸×¢²á¼ì²â
CTI9888À˹ά¼Ó˹¼ì²â¿ÉÒÔΪÄúÌṩ¡¾³¬Éù½àÑÀ×°±¸¡¿×¢²á¼ì²â½â¾ö¼Æ»®£¬¿ÉÁýÕֵļì²â·þÎñ¹æÄ£ÓУºÒ½ÁÆÆ÷еµçÆøÇå¾²¡¢EMC²âÊÔ¡¢ÉúÎïÏàÈÝÐÔ²âÊÔ¡¢°ü×°ÔËÊä¼°ÀÏ»¯ÊµÑ顢ϴåªÏû¶¾Ãð¾úÑéÖ¤µÈ·þÎñ¡£
³¬Éù½àÑÀ×°±¸²âÊÔ±ê×¼
º£ÄÚ×¢²á-¼ì²â¼Æ»®
ÏîĿ˵Ã÷ | ±ê×¼±àºÅ | ±ê×¼Ãû³Æ |
°²¹æ | GB 9706.1-2020 | Ò½ÓÃµçÆø×°±¸ µÚ1²¿·Ö£º»ù±¾Çå¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó |
YY/T 9706.106-2021 | Ò½ÓÃµçÆø×°±¸ µÚ 1-6 ²¿·Ö£º»ù±¾Çå¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó - ²¢Áбê×¼£º¿ÉÓÃÐÔ | |
YY 9706.111-2021 | Ò½ÓÃµçÆø×°±¸ µÚ1-11²¿·Ö£º»ù±¾Çå¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó ²¢Áбê×¼£ºÔÚ¼ÒÍ¥Õչ˻¤Ê¿ÇéÐÎÖÐʹÓõÄÒ½ÓÃµçÆø×°±¸ºÍÒ½ÓÃµçÆøÏµÍ³µÄÒªÇó | |
GB 9706.260-2020 | Ò½ÓÃµçÆø×°±¸ µÚ 2-60 ²¿·Ö£ºÑÀ¿Æ×°±¸µÄ»ù±¾Çå¾²ºÍ»ùÌìÐÔÄÜרÓÃÒªÇó | |
YY/T 0460-2009 | ³¬Éù½àÑÀ×°±¸ | |
YY/T 0751-2009 | ³¬Éù½àÑÀ×°±¸ Êä³öÌØÕ÷µÄÕÉÁ¿ºÍÐû²¼ | |
GB/T 14710-2009 | Ò½ÓõçÆ÷ÇéÐÎÒªÇó¼°ÊÔÑéÒªÁì | |
EMC | YY 9706.102-2021 | Ò½ÓÃµçÆø×°±¸ µÚ1-2²¿·Ö£º»ù±¾Çå¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó ²¢Áбê×¼£ºµç´Å¼æÈÝÒªÇóºÍÊÔÑé |
ÉúÎïÏàÈÝÐÔ | YY/T 0127.3-2014 | ¿ÚǻҽÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ3²¿·Ö£º¸ù¹ÜÄÚÓ¦ÓÃÊÔÑé |
YY/T 0127.9-2009 | ¿ÚǻҽÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ2µ¥Î»£ºÊÔÑéÒªÁì ϸ°û¶¾ÐÔÊÔÑé:ÇíÖ¬À©É¢·¨¼°ÂËĤÀ©É¢·¨ | |
YY/T 0127.13-2018 | ¿ÚǻҽÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ13²¿·Ö£º¿ÚÇ»ð¤Ä¤´Ì¼¤ÊÔÑé | |
GB/T 16886.1-2022 | Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ1²¿·Ö£ºÎ£º¦¹ÜÀíÀú³ÌÖÐµÄÆÀ¼ÛÓëÊÔÑé | |
GB/T 16886.5-2017 | Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ5²¿·Ö£ºÌåÍâϸ°û¶¾ÐÔÊÔÑé | |
GB/T 16886.10-2017 | Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ10²¿·Ö£º´Ì¼¤ÓëÆ¤·ôÖÂÃôÊÔÑé | |
GB/T 16886.23-2023 £¨2024-12-01ʵÑ飩 |
Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ23²¿·Ö£º´Ì¼¤ÊÔÑé | |
°ü×°ÔËÊä | GB /T 4857 | °ü×°ÔËÊäÊÔÑé |
ϴ媡¢Ïû¶¾¡¢Ãð¾úÖ¤ÑéÖ¤ | WS 310.1 / WS 310.2 / WS 310.3/ | Ï´åªÏû¶¾Ãð¾úÑéÖ¤ |
WS/T 367 / W S 506 |
¹ú¼Ê×¢²á-¼ì²â¼Æ»®
ÏîĿ˵Ã÷ | ±ê×¼±àºÅ | ±ê×¼Ãû³Æ |
°²¹æ | IEC 60601-1:2005/COR3:2022 | Ò½ÓÃµçÆø×°±¸ µÚ1²¿·Ö£º»ù±¾Çå¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó |
IEC 60601-1-6:2010+A1:2013+A2:2020 | Ò½ÓÃµçÆø×°±¸ µÚ 1-6 ²¿·Ö£º»ù±¾Çå¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó - ²¢Áбê×¼£º¿ÉÓÃÐÔ | |
IEC 60601-1-11: 2015+AMD1: 2020 | Ò½ÓÃµçÆø×°±¸ µÚ1-11²¿·Ö£º»ù±¾Çå¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó ²¢Áбê×¼£ºÔÚ¼ÒÍ¥Õչ˻¤Ê¿ÇéÐÎÖÐʹÓõÄÒ½ÓÃµçÆø×°±¸ºÍÒ½ÓÃµçÆøÏµÍ³µÄÒªÇó | |
IEC 80601-2-60:2019 | Ò½ÓÃµçÆø×°±¸ µÚ 2-60 ²¿·Ö£ºÑÀ¿Æ×°±¸µÄ»ù±¾Çå¾²ºÍ»ùÌìÐÔÄÜרÓÃÒªÇó | |
EMC | IEC 60601-1-2:2014+A1:2020 | Ò½ÓÃµçÆø×°±¸ µÚ1-2²¿·Ö£º»ù±¾Çå¾²ºÍ»ùÌìÐÔÄܵÄͨÓÃÒªÇó ²¢Áбê×¼£ºµç´Å¼æÈÝÒªÇóºÍÊÔÑé |
ÉúÎïÏàÈÝÐÔ | ISO 10993-1:2018 | Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process |
ISO 10993-5:2009 | Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity | |
ISO 10993-10:2021 | Biological evaluation of medical devices Part 10: Tests for skin sensitization | |
ISO 10993-23:2021 | Biological evaluation of medical devices Part 23: Tests for irritation | |
°ü×°ÔËÊä | ISTAϵÁÐ / ASTMD 4169 | °ü×°ÔËÊäÊÔÑé |
ÀÏ»¯ÊÔÑé | ASTM F1980 | ÀÏ»¯ÊÔÑé |
ϴ媡¢Ïû¶¾¡¢Ãð¾úÖ¤ÑéÖ¤ | AAMI TIR12£»AAMI TIR30 £» | Ï´åªÏû¶¾¼°Ãð¾úÊÖÒÕ²Ù×÷¹æ·¶ |
FDA Guidance |
±¸×¢£ºÉÏÊö±ê×¼°üÀ¨Á˲úÆ·ÊÖÒÕÒªÇóÖо³£Éæ¼°µ½µÄ±ê×¼£»ÆóÒµÐèҪƾ֤²úÆ·µÄÌØµãÒýÓÃÆäËûÊÊÓõıê×¼¡£
ÍêÕûÄÜÕý³£ÊÂÇéµÄÑù»ú£¬ÆäËûÏêϸÏêÇéÇë×ÉѯCTIÔÚÏ߿ͷþ¡£
1¡¢CTI¾ßÓÐרҵ×ÊÖÊ¡¢ÂÄÀú¸»ºñµÄÊÖÒÕר¼ÒÍŶӣ¬ÎªÄúÌṩרҵ×ÉѯºÍ·þÎñ¡£
2¡¢CTIÓµÓÐÏȽøµÄʵÑéÊÒ×°±¸£¬È·±£²âÊÔÊý¾ÝµÄ׼ȷºÍ¿É¿¿¡£
3¡¢CTI×÷ΪȫÇò¿Í»§ÐÅÈεĵÚÈý·½²âÊÔÈÏÖ¤»ú¹¹£¬ÎÒÃÇÊÇÄúÆ·Öʵı³Êé¡£
4¡¢ÎÒÃÇÒÀ¸½±é²¼È«ÇòµÄʵÑéÊÒÍøÂ磬ΪÄúÌṩÖÜÈ«ÍêÉÆµÄһվʽ²âÊÔÈÏÖ¤½â¾ö¼Æ»®¡£
CTIµÄÒ½ÁÆÆ÷е¼ì²âµÄ²âÊÔÖÜÆÚÊǶà¾Ã£¿
ÏÖʵÖÜÆÚÆ¾Ö¤Î¯ÍеIJúÆ·±ê×¼À´È·¶¨£¬ÇëÓëCTI¿Í·þÁªÏµÈ·ÈÏ¡£
CTIÒ½ÁÆÆ÷е¼ì²âµÄ²âÊÔÒªÁìÊÇʲô£¿
Õë¶Ô²úÆ·µÄ³ö¿ÚÒªÒÔ¼°¿Í»§Î¯ÍеÄÒªÇ󣬾ÙÐбê×¼¼ì²â¡£
CTI¹ØÓÚÑùÆ·µÄÁôÑùÖÜÆÚÊǶà¾Ã£¿
ÍËÑù¡£